Physician

Alberto R. Mizrachi, MD

According to 2025 Medicare claims, Alberto Mizrachi, MD (NPI: 1821203977) practices hematology/oncology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (NPI: 1508135799; TIN: 56-0529945) and primary practice location at 28078-7134. Mizrachi is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Mizrachi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 178 traditional Medicare patients, billed 498 HCPCS/CPT codes, and received $36,330 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 707 prescription claims across 116 beneficiaries totaling $1,149,723 in drug costs, led by Imbruvica (Ibrutinib). 2018 DME data shows 16 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $124,496 to $36,330. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $306,479 and ending at $1,149,723. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	269	2,093	$124,496
2016	341	4,426	$173,647
2017	384	11,087	$208,840
2018	402	7,880	$198,701
2019	110	277	$21,089
2020	113	388	$24,449
2021	180	708	$55,284
2022	181	654	$52,796
2023	203	762	$60,054
2024	178	498	$36,330

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	105	514	$306,479
2016	139	752	$397,611
2017	170	974	$854,775
2018	188	1,135	$1,457,397
2019	111	353	$515,917
2020	64	290	$502,716
2021	81	465	$823,961
2022	99	515	$587,073
2023	127	728	$872,393
2024	116	707	$1,149,723

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	16	$8,031
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	30	30	$118
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	44	107	$101
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	16	16	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	116	273	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	45	58	$41

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	13	364	$212,205
Tagrisso	Osimertinib Mesylate	12	360	$201,369
Lenalidomide	Lenalidomide	12	336	$129,264
Nubeqa	Darolutamide	12	360	$102,080
Eliquis	Apixaban	53	2,380	$44,706

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Alberto R. Mizrachi, MD?

Tedicare shows public-source Medicare data for Alberto R. Mizrachi, MD (NPI 1821203977), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alberto R. Mizrachi, MD have ACO affiliation data?

Alberto R. Mizrachi, MD is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Alberto R. Mizrachi, MD?

Alberto R. Mizrachi, MD is linked to THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (billing NPI 1508135799) in the available physician profile data.

Does Alberto R. Mizrachi, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.